TKIs (tyrosine kinase inhibitors) such as Gleevec, Sprycel, Tasigna and Bosulif have been shown to be highly effective in blocking the leukemia signals that drive the proliferation of white blood cells (WBC) in CML.
A number of environmental factors have been implicated in the development of CML. Recent studies have suggested that chronic, heavy smokers do have a greater risk of developing chronic myelogenous leukemia.
CML-IQ is pleased to announce CML radio – featuring news, views and insights about chronic myelogenous leukemia. In part 2, our panel of CML nurses address common questions people have after living with CML for a few years.
A great deal of attention has focused on the possibility that people with a deep response to their CML medication may be able to stop treatment at some point. But perhaps a more important question is: why keep taking a medication every day? Is this necessary, or can I take a break?
A common side effects of medications such as Gleevec is swelling (edema). This usually occurs around the eyes or involve the eyelids, which can become puffy; or the legs, which can become swollen or feel heavy.